Search Results
Nov 20, 2025, 05:26 ET 權威認可：全球首個胃癌圍術期「免化療」方案，H藥獲中國藥監局突破性療法認定
Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 May-Jun;74(3):229-263.
More news about: 復宏漢霖
Nov 19, 2025, 16:01 ET FDA GRANTS FULL APPROVAL TO AMGEN'S IMDELLTRA® IN EXTENSIVE STAGE SMALL CELL LUNG CANCER
a DLL3-targeting bispecific T-cell engager (BiTE), compared to standard of care in patients with relapsed small cell lung cancer (DeLLphi-304). J Clin Oncol. 2023;41(suppl 16):TPS8611. doi:10.1200/JCO.2023.41.16_suppl.TPS8611. Rudin CM, Mountzios GS, Sun L, et al. Tarlatamab
More news about: Amgen
Nov 18, 2025, 12:47 ET AbbVie Announces U.S. FDA Approval of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide for Relapsed or Refractory Follicular Lymphoma
10.3324/haematol.2022.281421.v Al-Tourah AJ, Gill KK, Chhanabhai M, et al. Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma. J Clin Oncol. 2008 Nov 10;26(32):5165-9. doi: 10.1200/JCO.2008.16.0283. Epub 2008 Oct 6. PMID: 18838711.vi Engelberts PJ, et al. DuoBody-CD3xCD20
More news about: AbbVie
Nov 18, 2025, 07:00 ET Armata Pharmaceuticals Announces Key Opinion Leader Webinar on S. aureus Bacteremia and AP-SA02 Hosted by Jones Research on November 25th at 10:00am EST
(Fowler, NEJM 2006), on the multinational trial of Merck V710 vaccine for S. aureus (Fowler, JAMA 2013), and on the Phase 2 trial (Fowler, J Clin Invest 2020) and Phase 3 trial (DISRUPT; Fowler, CID 2024) of bacteriophage-derived lysin (Exebacase) for S. aureus bacteremia. He was senior
More news about: Armata Pharmaceuticals, Inc.
Nov 17, 2025, 16:23 ET Ikonopedia Expands Adoption of Risk Aware™ as Radiology Practices Prioritize Proactive Breast Cancer Risk Assessment
Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi:
More news about: Ikonopedia
Nov 17, 2025, 11:49 ET ANS abre consulta pública para decidir sobre a inclusão de novo medicamento para dermatite atópica
[15] Williams H, Flohr C. How epidemiology has challenged 3 prevailing concepts about atopic dermatitis. J Allergy Clin Immunol. Jul 2006;118(1):209-13. doi:10.1016/j.jaci.2006.04.043 [16] Pontes LM SN, de Souza MLP,
More news about: Eli Lilly do Brasil
Nov 17, 2025, 11:07 ET Ácido hialurônico injetável não é tudo igual: conheça os diferentes géis e suas indicações
Dermatol Surg. 2016 Jun;42(6):699-709 3. Di Gregorio C et al. Clin Cosmet Investig Dermatol. 2022 Apr 14;15:681-690. 4. Talarico
More news about: Galderma
Nov 17, 2025, 09:27 ET 復宏漢霖與Organon共同宣佈美國首個帕妥珠單抗生物類似藥POHERDY®獲FDA批准
Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263. doi:10.3322/caac.21834
More news about: 復宏漢霖
Nov 13, 2025, 08:00 ET ORASIS PHARMACEUTICALS EXPANDS ACCESS TO QLOSI™ WITH NEW STARTER PACKS FOR EYE CARE PROFESSIONALS, BOLSTERING COMMERICAL ROLLOUT
al. Efficacy and Safety of CSF-1 (0.4% Pilocarpine Hydrochloride) in Presbyopia: Pooled Results of the NEAR Phase 3 Randomized, Clinical Trials. Clin Ther. 2024;46(2):104-113. doi:10.1016/j.clinthera.2023.12.0053 VUITY PI [package insert]. North Chicago, IL: AbbVie Inc.4
More news about: Orasis Pharmaceuticals
Nov 11, 2025, 08:30 ET Exploring Polycystic Kidney Disease Clinical Trials and New Treatments, Upcoming Webinar Hosted by Xtalks
International Ostroff C, Perrone RD, Czerwiec FS. Current Challenges and Perspectives on Developing a Clinical Trial Design for ADPKD. Clin J Am Soc Nephrol. 2022 Oct;17(10):1559-1562. doi: 10.2215/CJN.05360522. Epub 2022 Aug 23. PMID: 35998976; PMCID: PMC9528266.
More news about: Xtalks
Nov 10, 2025, 08:00 ET Johnson & Johnson lança plataforma VARIPULSE™ no Brasil e avança no tratamento da fibrilação atrial
Sciacca V, Bannmann K, et al. First experience using a novel variable loop catheter for mapping and pulsed field ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2025 May;48(5):471-479. doi:10.1111/pace.15177. Epub 2025 Mar 28. PMID:40153431; PMCID:PMC12063197 ix Fink T, Sciacca
More news about: Johnson & Johnson MedTech
Nov 07, 2025, 17:14 ET Boehringer awarded FDA Commissioner's National Priority Voucher for HERNEXEOS® in HER2 lung cancer
M. E. et al. Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas. Clin. cancer Res. an Off. J. Am. Assoc. Cancer Res. 18, 4910–4918 (2012). Galogre M, et al. A review of HER2 overexpression and
More news about: Boehringer Ingelheim
Nov 07, 2025, 16:07 ET Conheça os procedimentos que são eficazes para melhorar o rosto flácido após perda de peso induzida por medicamentos
Dermatol Surg. 2016 Jun;42(6):699-709 11. Di Gregorio C et al. Clin Cosmet Investig Dermatol. 2022 Apr 14;15:681-690. 12. Talarico S et al. Dermatol
More news about: Galderma
Nov 06, 2025, 08:07 ET Using Skin Biopsy Technology, CND Life Sciences Performs the 50,000th Syn-One Test® for Patients
10.1001/jamaneurol.2013.114.5Gummerson, CE, Tinaz, S, Santina, C, et al. Utilization of Skin Punch Biopsy for the Diagnosis of α-Synucleinopathy in Clinical Practice. Mov Disord Clin Pract. 05 August 2025. doi:
More news about: CND Life Sciences
Nov 06, 2025, 07:30 ET FDA approval of CAPLYTA® (lumateperone) has the potential to reset treatment expectations, offering hope for remission in adults with major depressive disorder
D, Ghelerter I, et al. The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States. J Clin Psychiatry. 2021;82(2):20m13699. doi:10.4088/JCP.20m13699 CAPLYTA® [Prescribing Information]. Bedminster,
More news about: Johnson & Johnson
Nov 04, 2025, 16:01 ET Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update
https://www.cancer.org/cancer/types/lung-cancer/about/key-statistics.html Kato, S. et al. RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients. Clin Cancer Res. 2017;23(8):1988-1997 doi: 10.1158/1078-0432.CCR-16-1679 The American Cancer Society. Key Statistics for Acute
More news about: Rigel Pharmaceuticals, Inc.
Nov 03, 2025, 07:00 ET Karyopharm Reports Third Quarter 2025 Financial Results and Highlights Recent Company Progress
Vergote I, et al. J Clin Oncol. 2023;41(35):5400-5410.
More news about: Karyopharm Therapeutics Inc.
Oct 30, 2025, 07:35 ET Knight Therapeutics anuncia a aprovação e o lançamento do MINJUVI® (tafasitamabe) na Argentina
C, Kamdar M. Considerações sobre o tratamento de pacientes com linfoma difuso de grandes células B refratário primário e com recidiva precoce. Am Soc Clin Oncol Educ Book. 2023 Jan;43:e390802 Duell, J et al. Resultados a longo prazo do estudo L-MIND de Fase II com tafasitamab
More news about: Knight Therapeutics Inc.
Oct 30, 2025, 07:35 ET Knight Therapeutics anuncia la aprobación y el lanzamiento de MINJUVI® (tafasitamab) en Argentina
Duarte C, Kamdar M. Management Considerations for Patients With Primary Refractory and Early Relapsed Diffuse Large B-Cell Lymphoma. Am Soc Clin Oncol Educ Book. 2023 Jan;43:e390802 Duell, J et al. Long-term outcomes from the Phase II L-MIND study of tafasitamab (MOR208)
More news about: Knight Therapeutics Inc.
Oct 27, 2025, 17:02 ET Autocuidado masculino: homens recorrem a procedimentos estéticos para realçar a beleza e cuidar da pele
2. Weiss RA et al. Dermatol Surg. 2016 Jun;42(6):699-709 3. Di Gregorio C et al. Clin Cosmet Investig Dermatol. 2022 Apr 14;15:681-690. 4. Talarico S et al. Dermatol Surg. 2015 Dec;41(12):1361-9.
More news about: Galderma
Oct 25, 2025, 11:00 ET BIMZELX® (bimekizumab-bkzx) Three-Year Rheumatology Data at ACR 2025 Demonstrated Sustained Inflammation Control in Psoriatic Arthritis and Axial Spondyloarthritis
adults: a review. JAMA. 2025;334(5):419-434. Ogdie A, Weiss P. The Epidemiology of Psoriatic Arthritis. Rheum Dis Clin North Am. 2015;41(4):545–68. Mease PJ, Gladman DD, Papp KA, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis
More news about: UCB
Oct 24, 2025, 12:18 ET 再鼎醫藥公布Zocilurtatug Pelitecan（前稱ZL-1310）最新一期臨床數據， 顯示其成為同類首創用於小細胞肺癌的靶向DLL3 ADC的潛力，並啟動全球三期注冊研究
3 Sabari JK, et al. Nat Rev Clin Oncol. 2017;14:549-561.
More news about: 再鼎醫藥
Oct 24, 2025, 12:14 ET Procedimentos estéticos injetáveis: quando é o momento certo para começar?
Dermatol Surg. 2016 Jun;42(6):699-709 2. Di Gregorio C et al. Clin Cosmet Investig Dermatol. 2022 Apr 14;15:681-690. 3. Talarico S et al. Dermatol Surg.
More news about: Galderma
Oct 22, 2025, 08:07 ET CND Life Sciences Announces NIH Grant to Study the Risk of Parkinson's Disease in Patients with Essential Tremor
10.1002/mds.22161.3 Louis ED, Berry D, Ghanem A, et al. Conversion Rate of Essential Tremor to Essential Tremor Parkinson Disease. Neurology Clin Practice, 2023;13(3).
More news about: CND Life Sciences
Oct 22, 2025, 08:00 ET Astellas Presents Preliminary Real-World VEOZAH™ (fezolinetant) Data From OPTION-VMS Phase IV Observational Study
Timmerman D, Donders G, et al. Treatment of menopausal vasomotor symptoms with fezolinetant, a neurokinin 3 receptor antagonist: a phase 2a trial. J Clin Endocrinol Metab. 2019;104:5893-5905.
More news about: Astellas Pharma Inc.